Centre Hospitalier Universitaire Dijon
Clinical trials sponsored by Centre Hospitalier Universitaire Dijon, explained in plain language.
-
Cheaper drug may match expensive biologic in artery disease trial
Disease control OngoingThis study compares two treatments—methotrexate and tocilizumab—for giant cell arteritis, a disease that causes inflamed arteries and can lead to vision loss. Both drugs aim to prevent relapses and reduce the need for long-term steroids, which have serious side effects. About 230…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Heart surgery kidney risk: could a different drug save more lives?
Disease control OngoingThis study compares two drugs, vasopressin and noradrenaline, used to maintain blood pressure after heart surgery. The goal is to see if vasopressin reduces the number of patients who develop acute kidney failure or die, compared to the standard drug noradrenaline. The trial incl…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Best way to stop arthritis drug may prevent relapses
Disease control OngoingThis study looks at 120 adults with giant cell arteritis (GCA) who are stable on tocilizumab. It compares stopping the drug all at once versus gradually tapering it off. The goal is to see which approach better prevents the disease from flaring up again. Researchers hope to find …
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Steroid flash before cancer surgery cuts complications by half?
Disease control OngoingThis study tests whether giving a short, high dose of corticosteroids right before surgery for digestive cancers can reduce serious complications and improve long-term outcomes. Inflammation during surgery may increase the risk of cancer return and slow recovery. The trial involv…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated May 13, 2026 15:58 UTC